Top View
- EPHX1 Mutations Cause a Lipoatrophic Diabetes Syndrome Due To
- T Anomaly, Cleft Lip and Palate, and Agenesis of the Corpus Callosum, with a Chromosomal Microdeletion Involving 1Q41 to 1Q42.12
- Effect of N-Acetylcysteine in COPD Patients with Different Microsomal Epoxide Hydrolase Genotypes
- Association Between EPHX1 Polymorphisms and Carbamazepine Metabolism in Epilepsy: a Meta‑Analysis
- EPHX1 Rs2234922 Polymorphism and Lung Cancer Susceptibility in Asian Populations: a Meta-Analysis
- Proteomic Analysis of RAW Macrophages Treated with Cgamp Or C-Di-GMP Reveals Differentially Cite This: RSC Adv.,2018,8, 36840 Activated Cellular Pathways†
- Epoxide Hydrolase (EPHX1) (NM 000120) Human Recombinant Protein – TP300621 | Origene
- Genetic Variation in Genes for the Xenobiotic-Metabolizing Enzymes CYP1A1, EPHX1, GSTM1, GSTT1, and GSTP1 and Susceptibility to Colorectal Cancer in Lynch Syndrome
- And Injury-Induced Vision Loss by Tet-Dependent Epigenetic Reprogramming
- Identi Cation of Hypoxia Induced Metabolism Associated Genes In
- EPHX1 Mutations Cause a Lipoatrophic Diabetes Syndrome Due
- EPHX1 Polymorphisms, COPD and Asthma in 47,000 Individuals and in Meta-Analysis
- Microsomal Epoxide Hydrolase Polymorphisms and Risk for Advanced Colorectal Adenoma
- Human Epoxide Hydrolase 1 / EPHX1 (T7 Tag) - Purified
- Seventy Genetic Variations in Human Microsomal and Soluble Epoxide Hydrolase Genes (EPHX1 and EPHX2) in the Japanese Population
- In Silico Discovery of Candidate Drugs Against Covid-19
- CYP1A1, CYP2E1 and EPHX1 Polymorphisms in Sporadic